Skip to search formSkip to main contentSkip to account menu

PentaLyte

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

ElectrolytesGlucoseHydroxyethyl Starch Derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches
Hemodilution has been associated with changes in hemostasis secondary to modulation of procoagulant activity. However, direct… 
2003
2003
The effect of the bovine hemoglobin oxygen therapeutic HBOC-201 on human neutrophil activation in vitro.
BACKGROUND We previously demonstrated that HBOC-201 is an efficient resuscitation fluid. However, little is known about its… 
2002
2002
PentaLyte®, a Novel Middle Molecular Weight Starch in Balanced Electrolyte Solution: [2002][A-440]
2001
2001
Pentalyte does not decrease heparinoid release but does decrease circulating thrombotic mediator activity associated with aortic occlusion-reperfusion in rabbits.
Hemorrhage and thrombosis are associated with major vascular and trauma surgery. Release of heparinoids and thrombotic mediators… 
1999
1999
Extreme, progressive isovolemic hemodilution with 5% human albumin, PentaLyte, or Hextend does not cause hepatic ischemia or histologic injury in rabbits.
BACKGROUND Physicians and their patients are greatly concerned about perioperative blood administration. Although isovolemic… 
1998
1998
PentaLyte decreases lung injury after aortic occlusion-reperfusion.
Lung injury often occurs after hepatoenteric ischemia, with xanthine oxidase (XO, an oxidant-generating enzyme), released from… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)